OVX836 influenza vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for OVX836 influenza vaccine, covering 2024-01-25 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg [Phase 2]